Atcharaporn Ontawong, Geetika Nehra, Bryan J. Maloney, Chutima S. Vaddhanaphuti, Björn Bauer, Anika M. S. Hartz
2025, 26, 4352 https://doi.org/10.3390/ijms26094352
Alzheimer’s disease (AD) is characterized by amyloid-beta (Aβ) pathology andis closely linked to oxidative stress, which contributes to blood–brain barrier leakage,renal dysfunction, and cognitive decline. We investigated the effects of N-acetyl cysteine(NAC), an FDA-approved antioxidant,
Louis T. Rodgers, Bryan J. Maloney, Anika M. S. Hartz, and Björn Bauer
2025, 17(5), 734; https://doi.org/10.3390/cancers17050734
In this study, we developed and tested a method for the fluorescence-guided resection of glioblastoma tumors in mouse models. Unlike previous models, our approach mimics clinical conditions by targeting tumors located deeper in the brain
Geetika Nehra, Bryan J. Maloney, Rebecca R. Smith, Wijitra Chumboatong, Erin L. Abner, Peter T. Nelson, Björn Bauer & Anika M. S. Hartz
(2025) 22:4 https://doi.org/10.1186/s12987-024-00615-8
This study highlights plasma S100β as a promising non-invasive biomarker for early detection and progression monitoring of Alzheimer’s disease. Given its strong association with cognitive decline and AD pathology, S100β could serve as a valuable